685 related articles for article (PubMed ID: 21873140)
21. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
Schwartz RA; McDonough PH; Lee BW
J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
[TBL] [Abstract][Full Text] [Related]
22. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases.
Lee HY; Tey HL; Pang SM; Thirumoorthy T
Lupus; 2011 May; 20(6):647-52. PubMed ID: 21148602
[TBL] [Abstract][Full Text] [Related]
23. Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis.
Yun SJ; Choi MS; Piao MS; Lee JB; Kim SJ; Won YH; Lee SC
Dermatology; 2008; 217(3):254-9. PubMed ID: 18667824
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
[TBL] [Abstract][Full Text] [Related]
25. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology.
Niemeijer IC; van Praag MC; van Gemund N
Arch Gynecol Obstet; 2009 Nov; 280(5):851-4. PubMed ID: 19277691
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between erythema multiforme exudativum and the Stevens-Johnson and Lyell syndromes].
Neshkov NS; Provizion LN; Kalpakhch'ian PI; Shcherbakov VA
Vestn Dermatol Venerol; 1981 Mar; (3):53-5. PubMed ID: 7257598
[No Abstract] [Full Text] [Related]
27. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
[TBL] [Abstract][Full Text] [Related]
28. Childhood epidermal necrolysis and erythema multiforme major: a multicentre French cohort study of 62 patients.
Giraud-Kerleroux L; Bellon N; Welfringer-Morin A; Leclerc-Mercier S; Costedoat I; Coquin J; Brun A; Roguedas-Contios AM; Bernier C; Milpied B; Tétart F; Du Thanh A; Cordel N; Bensaid B; Fargeas C; Tauber M; Renolleau S; Boralevi F; Ingen-Housz-Oro S; Bodemer C
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2051-2058. PubMed ID: 34157175
[TBL] [Abstract][Full Text] [Related]
29. [Interrelation of erythema multiforme exudativum, the Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome)].
Anton'eva AA; Shevarova VN
Vestn Dermatol Venerol; 1981 Jul; (7):29-30. PubMed ID: 7293469
[No Abstract] [Full Text] [Related]
30. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
Wolf R; Matz H; Marcos B; Orion E
Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z
Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
[TBL] [Abstract][Full Text] [Related]
32. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
[TBL] [Abstract][Full Text] [Related]
33. [Erythema multiforme exudativum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's syndrome) and their interrelationship].
Kalamkarian AA; Samsonov VA
Vestn Dermatol Venerol; 1980 Mar; (3):36-42. PubMed ID: 6990649
[No Abstract] [Full Text] [Related]
34. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
35. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
[TBL] [Abstract][Full Text] [Related]
36. Approach to the hospitalized patient with targetoid lesions.
Hughey LC
Dermatol Ther; 2011; 24(2):196-206. PubMed ID: 21410609
[TBL] [Abstract][Full Text] [Related]
37. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
Wanat KA; Anadkat MJ; Klekotka PA
J Am Acad Dermatol; 2009 Apr; 60(4):589-94. PubMed ID: 19217690
[TBL] [Abstract][Full Text] [Related]
38. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
39. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
Worswick S; Cotliar J
Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610
[TBL] [Abstract][Full Text] [Related]
40. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
